Altered gene expression in rat colonic adenocarcinomas induced in an azoxymethane plus 2-amino-1-methyl-6-phenylimidazo[4,5-b]- pyridine initiation-promotion model

Oncology

Volumn 73, Issue 3-4, 2008, Pages 252-260

  Doi, Kenichiro ^a   Hagihara, Atsushi ^b   Wei, Min ^a   Yunoki, Takayuki ^a   Fukushima, Shoji ^c   Wanibuchi, Hideki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c Japan Bioassay Research Center   (Japan)

Author keywords

Azoxymethane; Microarray; PhIP; Rat colon carcinogenesis; RT PCR

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; AZOXYMETHANE; HEAT SHOCK PROTEIN 90; STAT1 PROTEIN; VASCULOTROPIN A; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COLON ADENOCARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; FISCHER 344 RAT; GENE EXPRESSION; GENOTOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANIMALS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; IMIDAZOLES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 43049134142     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000127423     Document Type: Article

References (36)

1. Sugimura T: Nutrition and dietary carcinogens. Carcinogenesis 2000;21:387-395.
2. Wakabayashi K, Nagao M, Esumi H, Sugimura T: Food-derived mutagens and carcinogens. Cancer Res 1992;52:2092s-2098s.
3. Wakabayashi K, Ushijima H, Takahashi M, Nukaya H, Kim SB, Hirose M, Ochiai M, Sugimura T, Nagao M: Exposure to heterocyclic amines. Environ Health Perspect 1993;99:129-133.
4. Manabe S, Suzuki H, Wada O, Ueki A: Detection of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in beer and wine. Carcinogenesis 1993;14:899-901.
5. Manabe S, Tohyama K, Wada O, Aramaki T: Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in cigarette smoke condensate. Carcinogenesis 1991;12:1945-1947.
6. Augustsson K, Skog K, Jagerstad M, Steineck G: Assessment of the human exposure to heterocyclic amines. Carcinogenesis 1997;18:1931-1935.
7. Sugimura T, Wakabayashi K, Nakagama H, Nagao M: Heterocyclic amines: mutagens/ carcinogens produced during cooking of meat and fish. Cancer Sci 2004;95:290-299.
8. Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, Sugimura T: A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 1991;12:1503-1506.
9. Hasegawa R, Sano M, Tamano S, Imaida K, Shirai T, Nagao M, Sugimura T, Ito N: Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[ 4,5-b]- pyridine (PhIP) carcinogenicity in rats. Carcinogenesis 1993;14:2553-2557.
10. Shirai T, Sano M, Tamano S, Takahashi S, Hirose M, Futakuchi M, Hasegawa R, Imaida K, Matsumoto K, Wakabayashi K, Sugimura T, Ito N: The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[ 4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997;57:195-198.
11. Nakai Y, Nelson WG, DeMarzo AM: The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res 2007;67:1378-1384.
12. Ubagai T, Ochiai M, Kawamori T, Imai H, Sugimura T, Nagao M, Nakagama H: Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine in combination with a high fat diet. Carcinogenesis 2002;23:197-200.
13. Yu M, Jones ML, Gong M, Sinha R, Schut HA, Snyderwine EG: Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high-and low-fat diets. Carcinogenesis 2002;23:877-884.
14. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.
15. Futakuchi M, Hirose M, Imaida K, Takahashi S, Ogawa K, Asamoto M, Miki T, Shirai T: Chemoprevention of 2-amino-1-methyl-6-phenylimidazo-[4,5-b] pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5- trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats. Carcinogenesis 2002;23:283-287.
16. Hasegawa R, Tanaka H, Tamano S, Shirai T, Nagao M, Sugimura T, Ito N: Synergistic enhancement of small and large intestinal carcinogenesis by combined treatment of rats with five heterocyclic amines in a medium-term multi-organ bioassay. Carcinogenesis 1994;15:2567-2573.
17. Fukushima S, Wanibuchi H, Morimura K, Iwai S, Nakae D, Kishida H, Tsuda H, Uehara N, Imaida K, Shirai T, Tatematsu M, Tsukamoto T, Hirose M, Furukawa F: Existence of a threshold for induction of aberrant crypt foci in the rat colon with low doses of 2-amino-1-methyl-6-phenolimidazo[4,5-b] pyridine. Toxicol Sci 2004;80:109-114.
18. Doi K, Wanibuchi H, Salim EI, Morimura K, Kinoshita A, Kudoh S, Hirata K, Yoshikawa J, Fukushima S: Lack of large intestinal carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[ 4,5-b]pyridine at low doses in rats initiated with azoxymethane. Int J Cancer 2005;115:870-878.
19. Takayama T, Ohi M, Hayashi T, Miyanishi K, Nobuoka A, Nakajima T, Satoh T, Takimoto R, Kato J, Sakamaki S, Niitsu Y: Analysis of K-ras, APC, and β-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 2001;121:599-611.
20. Hokaiwado N, Asamoto M, Tsujimura K, Hirota T, Ichihara T, Satoh T, Shirai T: Rapid analysis of gene expression changes caused by liver carcinogens and chemopreventive agents using a newly developed three-dimensional microarray system. Cancer Sci 2004;95:123-130.
21. Kuribayashi M, Asamoto M, Suzuki S, Hokaiwado N, Ogawa K, Shirai T: Lack of modification of 2-amino-3,8-dimethylimidazo[ 4,5-f]quinoxaline (MeIQx) rat hepatocarcinogenesis by caffeine, a CYP1A2 inducer, points to complex counteracting influences. Cancer Lett 2006;232:289-299.
22. Bromberg J: Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Res 2000;2:86-90.
23. Xu X, Fu X-Y, Plate J, Chong A: IFN-γ induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res 1998;58:2832-2837.
24. McDermott U, Longley DB, Galligan L, Allen W, Wilson T, Johnston PG: Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer. Cancer Res 2005;65:8951-8960.
25. Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, Grandis JR: Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst 2006;98:181-189.
26. Hanada T, Kobayashi T, Chinen T, Saeki K, Takaki H, Koga K, Minoda Y, Sanada T, Yoshioka T, Mimata H, Kato S, Yoshimura A: IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J Exp Med 2006;203:1391-1397.
27. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-3968.
28. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ: Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 1997;90:3322-3331.
29. Jung YD, Nakano K, Liu W, Gallick GE, Ellis LM: Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells. Cancer Res 1999;59:4804-4807.
30. Zhang X, Gaspard JP, Chung DC: Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Cancer Res 2001;61:6050-6054.
31. Reinmuth N, Liu W, Fan F, Jung YD, Ahmad SA, Stoeltzing O, Bucana CD, Radinsky R, Ellis LM: Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer. Clin Cancer Res 2002;8:3259-3269.
32. Lauber SN, Ali S, Gooderham NJ: The cooked food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent oestrogen: a mechanistic basis for its tissue-specific carcinogenicity. Carcinogenesis 2004;25:2509-2517.
33. Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ: A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003;425:407-410.
34. Fujiwara K, Ochiai M, Ohta T, Ohki M, Aburatani H, Nagao M, Sugimura T, Nakagama H: Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[ 4,5-b]pyridine. Carcinogenesis 2004;25:1495-1505.
35. Nakagama H, Nakanishi M, Ochiai M: Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP. Cancer Sci 2005;96:627-636.
36. Shan L, He M, Yu M, Qiu C, Lee NH, Liu ET, Snyderwine EG: cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthra cene. Carcinogenesis 2002;23:1561-1568.